echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > JCEM: Vitamin D levels in hospitalized patients with SARS-CoV-2 infection

    JCEM: Vitamin D levels in hospitalized patients with SARS-CoV-2 infection

    • Last Update: 2022-02-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Background: Several lines of evidence may support a role for vitamin D status in SARS-CoV-2 infection
    .


    First, vitamin D deficiency is a common condition around the world, and serum 25-hydroxyvitamin D (25-OHD) levels are seasonal and geographic


    Vitamin D deficiency is a common condition around the world, and serum 25-hydroxyvitamin D (25-OHD) levels are seasonal and geographic


    Objective: To assess serum 25-hydroxyvitamin D (25-OHD) levels in hospitalized patients with COVID-19, and to analyze the possible impact of vitamin D levels on disease severity
    .

    Methods: A retrospective case-control study was performed on 216 COVID-19 patients and 197 normal people
    .


    The serum 25-OHD levels of the two groups were measured


    RESULTS: Of 216 patients, 19 were taking vitamin D supplements and analyzed separately
    .


    In COVID-19 patients, the mean ± SD of 25-OHD levels was 13.


    Table 1 Main characteristics of patients with COVID-19 assessed according to vitamin D deficiency status

    Table 1 Main characteristics of patients with COVID-19 assessed according to vitamin D deficiency status

    Table 2 Main characteristics of oral and non-oral vitamin D supplementation in patients with COVID-19 on admission

    Table 2 Main characteristics of oral and non-oral vitamin D supplementation in patients with COVID-19 on admission

    Figure 1 Serum vitamin D levels in hospitalized COVID-19 patients with and without active oral vitamin D supplementation and in population-based control patients, according to sex
    .


    Gray lines represent males, white lines represent females


    Figure 1 Serum vitamin D levels in hospitalized COVID-19 patients with and without active oral vitamin D supplementation and in population-based control patients, according to sex


    Figure 2 Comparison of patients with new coronary pneumonia (excluding patients taking vitamin D on admission) and control groups according to different time periods of serum 25OHD levels
    .

    Figure 2 Comparison of patients with new coronary pneumonia (excluding patients taking vitamin D on admission) and control groups according to different time periods of serum 25OHD levels
    .


    Figure 3 Correlation of serum 25OHD with inflammatory markers (A ferritin, BD-dimer, C C-reactive protein)
    .

    Figure 3 Correlation of serum 25OHD with inflammatory markers (A ferritin, BD-dimer, C C-reactive protein)
    .


    Conclusions: Hospitalized COVID-19 patients had lower levels of 25-OHD than population-based controls, and these patients had a higher prevalence of vitamin D deficiency
    .


    We did not find any relationship between vitamin D levels or vitamin deficiency and disease severity


    Hospitalized COVID-19 patients had lower 25-OHD levels than population-based controls, and these patients had a higher prevalence of vitamin D deficiency


    Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection.


     

    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.